Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial

Introduction. A large number of patients with chronic hepatitis C have not been cured with interferon-based therapy. Therefore, we evaluated the efficacy of amantadine combined with the standard of care (pegylated interferon plus ribavirin) in patients who had not responded to or had relapsed after...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Mario G. Pessôa, Hugo Cheinquer, Paulo R.L. Almeida, Giovanni F. Silva, Maria Patelli J.S. Lima, Raymundo Paraná, Marco A. Lacerda, Edison R. Parise, José R.B. Pernambuco, Suelene S. Pedrosa, Rosângela Teixeira, Hoel Sette, Jr, Fernando Tatsch
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2012-01-01
Serija:	Annals of Hepatology
Teme:	Hepatitis C Re-treatment Peginterferon alfa-2a (40KD) Amantadine
Online dostop:	http://www.sciencedirect.com/science/article/pii/S1665268119314863
Oznake:	Označite Brez oznak, prvi označite!